In 2023, mortality from genitourinary system diseases in the US stood at approximately 81.68 thousand deaths. Forecasted data indicates a consistent rise in mortality, reaching 89.41 thousand deaths by 2028. Year-on-year, this translates to a gradual increase: 1.88% from 2024 to 2025, 1.84% from 2025 to 2026, 1.78% from 2026 to 2027, and 1.74% from 2027 to 2028. The compound annual growth rate (CAGR) over this period is estimated at 1.80%.
Future trends to watch include potential advancements in medical treatments, healthcare access inequalities, and demographic changes like an aging population, which could significantly impact these mortality trends.
